The key finding
A comprehensive 2025 review published in Fitoterapia reveals that seeds from two closely related plants—Descurainia sophia and Lepidium apetalum—contain more than 200 distinct chemical compounds that may offer therapeutic benefits for lung, heart, and kidney diseases. Known collectively as “Tinglizi” in traditional Chinese medicine, these seeds have been used for centuries across China, Iran, India, Korea, and Japan to treat respiratory ailments. Modern pharmacological research now shows these traditional uses align with measurable biological activities, particularly for pulmonary diseases and heart complications arising from lung conditions.
What the study looked like
This was a comprehensive literature review examining decades of botanical, chemical, and pharmacological research on Descurainia sophia and Lepidium apetalum seeds. The authors synthesized findings from ethnopharmacological studies documenting traditional uses across multiple cultures, phytochemical analyses identifying the seeds’ chemical constituents, and modern laboratory studies testing biological activities. Rather than conducting new experiments, the researchers compiled existing evidence to map what is currently known—and unknown—about these medicinal seeds. The review specifically focused on the correlation between the seeds’ 200+ identified compounds and their observed effects in various disease models, highlighting both validated traditional applications and emerging potential uses as health foods and agricultural pesticides.
Why researchers think this happened
The authors propose that the medicinal effects stem from the seeds’ complex chemical profile, which includes glucosinolates (sulfur-containing compounds found in plants like broccoli and mustard) and steroidal compounds with potential heart-strengthening properties. Traditional practitioners observed that these seeds helped with breathing difficulties and associated heart problems—observations that modern research links to specific bioactive molecules. The chemical similarity between Descurainia sophia and Lepidium apetalum seeds may explain why traditional medicine systems treated them interchangeably as “Tinglizi,” though the review notes subtle compositional differences that could account for varying clinical applications. The researchers emphasize that while laboratory studies support traditional respiratory and cardiovascular uses, the precise mechanisms connecting specific chemical compounds to specific health effects remain incompletely understood and require further investigation.
How to read this carefully
This review summarizes existing research rather than presenting new clinical data, so its conclusions depend on the quality of prior studies, which vary widely in design and rigor. The pharmacological evidence comes largely from laboratory and animal studies—human clinical trials are limited, making it premature to draw firm conclusions about effectiveness in people. The authors explicitly note that while traditional uses are “demonstrated” by modern research, the correlations between chemical constituents and pharmacological effects “still need to be confirmed.” Important chemical components, particularly the steroidal compounds and glucosinolates, remain inadequately studied. Additionally, the review points out that despite treating the two plant species as equivalent in traditional practice, systematic comparative studies examining their compositional and therapeutic differences are lacking. Readers should view this as a research roadmap rather than evidence of proven medical treatments.
What this means for everyday life
For those interested in traditional medicine or plant-based therapeutics, this review highlights how ancient healing practices can guide modern scientific investigation. The convergence of traditional respiratory uses with contemporary pharmacological findings suggests these seeds warrant serious research attention, particularly given the global burden of lung and heart disease. However, the significant gaps in understanding—especially regarding which compounds produce which effects and optimal dosing—mean these seeds should not be viewed as ready alternatives to established treatments. The finding that over 200 compounds exist in these small seeds illustrates nature’s chemical complexity and why isolating “active ingredients” from traditional remedies proves challenging. For researchers and health professionals, this review underscores the need for rigorous comparative studies and human clinical trials before these traditional medicines can be responsibly integrated into modern healthcare. Given these findings, those using or considering traditional preparations containing these seeds might discuss them with healthcare providers, particularly if managing respiratory or cardiovascular conditions.